Acta Haematologica
Overview
Acta Haematologica is a peer-reviewed medical journal that focuses on the study of blood and blood disorders. It publishes original research articles, reviews, and case reports related to hematology, including hematopoiesis, hematological malignancies, transfusion medicine, and coagulation disorders. The journal serves as a valuable resource for hematologists, oncologists, and researchers interested in advancing knowledge and understanding in the field of hematology.
Details
Details
Abbr.
Acta Haematol
Start
1948
End
Continuing
Frequency
Eight no. a year
p-ISSN
0001-5792
e-ISSN
1421-9662
Country
Switzerland
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 5907
62
SJR / Ranks: 6492
686
CiteScore / Ranks: 5214
4.90
JIF / Ranks: 4480
2.4
Recent Articles
1.
2.
Mascarenhas J, Bose P, Hillis C, Yacoub A, Chaer F, Maze D, et al.
Acta Haematol
. 2025 Mar;
:1-11.
PMID: 40043697
Ropeginterferon alfa-2b-njft (ropeg) was approved and recommended as a preferred cytoreductive treatment for polycythemia vera (PV). The approved regimen requires an initial dose of 100 μg or 50 μg if...
3.
4.
Shen C, Wang F
Acta Haematol
. 2025 Feb;
:1-12.
PMID: 39938486
Introduction: Ferroptosis offers novel perspectives for treating multiple blood-related diseases, yet its role in aplastic anaemia (AA) is rare. This study aimed to explore key ferroptosis-related genes (FRGs) in AA...
5.
Patel R, Boselli D, Meadors P, Begley S, Bose R, Ai J, et al.
Acta Haematol
. 2025 Feb;
:1-18.
PMID: 39938485
INTRODUCTION Distress negatively affects cancer outcomes. The National Comprehensive Cancer Network (NCCN) recommends screening patients for distress by a self-reported scale (0-10) and to refer those with scores ≥ 4...
6.
Huang M, Zeng Q, Chen D, Yang C, Yang Y, Zhou M, et al.
Acta Haematol
. 2025 Feb;
:1-14.
PMID: 39933493
Abstract： Introduction: Many reports indicate that the occurrence of multiple myeloma (MM) is closely related to inflammation and immunity. Although the survival rates have been gradually improving in recent years,...
7.
Oanunu U, Gross Even Zohar N, Even-Zohar N, Aumann S, Vainstein V, Gural A, et al.
Acta Haematol
. 2025 Jan;
:1-11.
PMID: 39884265
Introduction: The treatment protocols of adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) have evolved, with the advent of pediatric-based regimens, measurable residual disease monitoring, and mutation...
8.
Yang J, Hu Q, Lu J, Wang J, Wu D, Fei X, et al.
Acta Haematol
. 2025 Jan;
:1-9.
PMID: 39870056
Introduction: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe hypersensitivity reaction rarely documented in patients with multiple myeloma (MM). Methods: In our retrospective study of 108 newly...
9.
A Prognostic Survival Model Based on Endocrine-Related Gene Expression in Acute Myelogenous Leukemia
Lv W, Wang Y, Hu F, Huang H, Cui Y, Song Y, et al.
Acta Haematol
. 2025 Jan;
:1-15.
PMID: 39809225
Introduction: Accurate prediction of survival in patients with acute myelogenous leukemia (AML) is challenging. Therefore, we developed a predictive survival model using endocrine-related gene expression to identify an endocrine signature...
10.
Cho H, Baek D, Kim J, Jang Y, Lee Y, Moon J, et al.
Acta Haematol
. 2025 Jan;
1-14.
PMID: 39799934
Introduction: This study aimed to analyze the survival outcomes and adverse events (AEs) associated with the long-term use of tyrosine kinase inhibitors (TKIs) and to assess health-related quality of life...